Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-16-010660
Filing Date
2016-06-09
Accepted
2016-06-09 16:02:06
Documents
54
Period of Report
2016-04-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 501809
2 ex31-1.htm EX-31.1 8844
3 ex31-2.htm EX-31.2 8764
4 ex32-1.htm EX-32.1 4698
5 ex32-2.htm EX-32.2 4795
  Complete submission text file 0001493152-16-010660.txt   2415746

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE oncs-20160430.xml EX-101.INS 322155
7 XBRL SCHEMA FILE oncs-20160430.xsd EX-101.SCH 34521
8 XBRL CALCULATION FILE oncs-20160430_cal.xml EX-101.CAL 40517
9 XBRL DEFINITION FILE oncs-20160430_def.xml EX-101.DEF 104086
10 XBRL LABEL FILE oncs-20160430_lab.xml EX-101.LAB 227957
11 XBRL PRESENTATION FILE oncs-20160430_pre.xml EX-101.PRE 169768
Mailing Address 5820 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 5820 NANCY RIDGE DRIVE SAN DIEGO CA 92121 (858) 210-7333
ONCOSEC MEDICAL Inc (Filer) CIK: 0001444307 (see all company filings)

EIN.: 980573252 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-54318 | Film No.: 161706011
SIC: 2834 Pharmaceutical Preparations